Royal Biologics Announces U.S. Commercial Launch of BIOINCYTE™ PRFM
Royal Biologics, a company specializing in Advanced Cellular Technologies & Enhanced Autologous Solutions, today announces the commercial launch of BIOINCYTE™ PRFM, a next-generation Platelet Rich Plasma...